Cargando…
Clinical scale zinc finger nuclease (ZFN)-driven gene-editing of PD-1 in tumor infiltrating lymphocytes (TIL) for the potential treatment of metastatic melanoma
Autores principales: | Beane, Joal D, Lee, Gary K, Zheng, Zhili, Gandhi, Nimisha, Abate-Daga, Daniel, Bharathan, Mini, Black, Mary, Mendel, Matthew, Yu, Zhiya, Kassim, Sadik H, Chandran, Smita, Giedlin, Martin, Ando, Dale, Rebar, Ed, Reik, Andreas, Holmes, Michael, Gregory, Philip D, Restifo, Nicholas P, Rosenberg, Steven A, Morgan, Richard A, Feldman, Steven A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288583/ http://dx.doi.org/10.1186/2051-1426-2-S3-P2 |
Ejemplares similares
-
Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing
por: Yan, Wei, et al.
Publicado: (2013) -
ZFN-Site searches genomes for zinc finger nuclease target sites and off-target sites
por: Cradick, Thomas J, et al.
Publicado: (2011) -
Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening
por: Dansithong, Warunee, et al.
Publicado: (2015) -
Utility of I-SceI and CCR5-ZFN nucleases in excising selectable marker genes from transgenic plants
por: Pathak, Bhuvan P., et al.
Publicado: (2019) -
Correction: Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening
por: Dansithong, Warunee, et al.
Publicado: (2021)